Return
Biography
Yong Sang Song

Prof. Yong Sang Song

Seoul National University, Korea
Professor


Email:yssong@snu.ac.kr


Qualifications

1991 Ph.D., Seoul National University

1985 M.Sc., Seoul National University
1977 M.D., Seoul National University


Publication (selected)

  1. Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis. Kim HS, Kim TH, Chung HH, Song YS. Br J Cancer. 2014 Feb 11. (Corresponding author)
  2. Prognosis of Adenosquamous Carcinoma Compared With Adenocarcinoma in Uterine Cervical Cancer: A Systematic Review and Meta-Analysis of Observational Studies. Lee JY, Lee C, Hahn S, Kim MA, Kim HS, Chung HH, Kim JW, Park NH, Song YS. Int J Gynecol Cancer. 2014 Jan 8. [Epub ahead of print]
  3. Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture. Suh DH, Kim TH, Kim JW, Kim SY, Kim HS, Lee TS, Chung HH, Kim YB, Park NH, Song YS. J Gynecol Oncol. 2013 Oct;24(4):352-8. doi: 10.3802/jgo.2013.24.4.352. Epub 2013 Oct 2.
  4. Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer. Chung HH, Cheon GJ, Kang KW, Kim JW, Park NH, Song YS. Eur J Nucl Med Mol Imaging. 2013 Nov 14. [Epub ahead of print]
  5. Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture. Suh DH, Kim TH, Kim JW, Kim SY, Kim HS, Lee TS, Chung HH, Kim YB, Park NH, Song YS. J Gynecol Oncol. 2013 Oct;24(4):352-8. doi: 10.3802/jgo.2013.24.4.352. Epub 2013 Oct 2.
  6. Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis.Kim HS, Kim T, Lee ES, Kim HJ, Chung HH, Kim JW, Song YS, Park NH. Cancer Res Treat. 2013 Sep;45(3):193-201. doi: 10.4143/crt.2013.45.3.193. Epub 2013 Sep 30.
  7. The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells. Im-Aram A, Farrand L, Bae SM, Song G, Song YS, Han JY, Tsang BK. PLoS One. 2013 Sep 23;8(9):e75455.
  8. Cancer-specific Therapeutic Potential of Resveratrol: Metabolic Approach against Hallmarks of Cancer Suh DH, Kim MK, Kim HS, Chung HH, Song YS. Functional Foods in Health and Disease. 2013 Aug 26 (Corresponding author)
  9. Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer.
  10. Suh DH, Kim MA, Kim H, Kim MK, Kim HS, Chung HH, Kim YB, Song YS. Clin Exp Med. 2013 Aug 15 (corresponding author)
  11. Genotypic prevalence of human papillomavirus infection during normal pregnancy: A cross-sectional study. Kim YH, Park JS, Norwitz ER, Park JW, Kim SM, Lee SM, Park CW, Kim BJ, Koo JN, Oh IH, Song YS. J Obstet Gynaecol Res. 2013 Jul 2. (corresponding author)
  12. Prognostic value of preoperative metabolic tumor volume measured by 18F-FDG PET/CT and MRI in patients with endometrial cancer. Gynecol Oncol. 2013 Jun 19. [Epub ahead of print] Chung HH, Lee I, Kim HS, Kim JW, Park NH, Song YS, Cheon GJ.
  13. Risk of Vertical Transmission of Human Papillomavirus throughout Pregnancy: A Prospective Study. Lee SM, Park JS, Norwitz ER, Koo JN, Oh IH, Park JW, Kim SM, Kim YH, Park CW, Song YS. PLoS One. 2013 Jun 13;8(6):e66368. (corresponding author)
  14. Impact of intraoperative rupture of the ovarian capsule on prognosis in patients with early-stage epithelial ovarian cancer: a meta-analysis. Kim HS, Ahn JH, Chung HH, Kim JW, Park NH, Song YS, Lee HP, Kim YB. Eur J Surg Oncol. 2013 Mar;39(3):279-89
  15. Necessity of Education for Oral Contraceptive Use in Korea: Results from the Fourth Korean National Health and Nutrition Examination Survey 2007-2009. Lee JY, Park SM, Ko YJ, Song YS.
  16. Gynecol Obstet Invest. 2013 May 31. (corresponding author)
  17. Prevalence of the metabolic syndrome and associated factors in korean cancer survivors. Lee JY, Park NH, Song YS, Park SM, Lee HW, Kim KH, Choi KH. Asian Pac J Cancer Prev. 2013;14(3):1773-80.
  18. Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer. Lee HJ, Kim HS, Park NH, Chung HH, Kim JW, Song YS. Cancer Res Treat. 2013 Mar;45(1):40-7. doi: 10.4143/crt.2013.45.1.40. Epub 2013 Mar 31.
  19. Mitochondrial permeability transition pore as a selective target for anti-cancer therapy. Suh DH, Kim MK, Kim HS, Chung HH, Song YS. Front Oncol. 2013;3:41. doi: 10.3389/fonc.2013.00041. Epub 2013 Mar 8. (corresponding author)
  20. A feeder-free, defined three-dimensional polyethylene glycol-based extracellular matrix niche for culture of human embryonic stem cells. Jang M, Lee ST, Kim JW, Yang JH, Yoon JK, Park JC, Ryoo HM, van der Vlies AJ, Ahn JY, Hubbell JA, Song YS, Lee G, Lim JM. Biomaterials. 2013 Feb 16.
  21. Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studies. Lee JY, Myung SK, Song YS.  Gynecol Oncol. 2013 Feb 16. (corresponding author)
  22. Diabetes Mellitus and Ovarian Cancer Risk: A Systematic Review and Meta-Analysis of Observational Studies. Lee JY, Jeon I, Kim JW, Song YS, Yoon JM, Park SM. Int J Gynecol Cancer. 2013 Jan 24.
  23. Correction: SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer. Lim W, Kim HS, Jeong W, Ahn SE, Kim J, Kim YB, Kim MA, Kim MK, Chung HH, Song YS, Bazer FW, Han JY, Song G. PLoS One. 2013 May 29;8(5).
  24. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis. Kim HS, Sardi JE, Katsumata N, Ryu HS, Nam JH, Chung HH, Park NH, Song YS, Behtash N, Kamura T, Cai HB, Kim JW. Eur J Surg Oncol. 2013 Feb;39(2):115-24.